JAMA Oncology

Medications

First mutation-targeted bladder cancer drug may be under-used

The first bladder cancer drug targeting a cancer-driving gene mutation has been used relatively little despite its clear efficacy in a clinical trial, suggests a study from researchers at the Perelman School of Medicine at ...

Oncology & Cancer

Gut microbiome may alter response to cancer therapy

Since ancient times, our gut microbiome, home to a vast number of bacteria, viruses, fungi, and other microorganisms, has been thought to influence many aspects of human health. Most recently, sequencing technology has shown ...

page 13 from 40